Case File
efta-01901966DOJ Data Set 10OtherEFTA01901966
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01901966
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Melanie SpineIla
From:
Jeffrey Epstein
Sent
Sat 3/2/2013 12:25:38 AM
Subject Fwd: KUE
Forwarded message
From: Jeffrey Epstein
Date: Friday, March 1, 2013
Subject: KUE
To: Eileen Alexanderson does goldman have a current valuation;?
On Fri, Mar 1, 2013 at 6:04 PM, Eileen Alexanderson wrote:
This is only 1/2 the PPM-but contains what I think is relevant. See pages 37--this is where IPO
concept comes into play and 125 re transferability.
Material from investor meeting was also an inch thick with no summary just presentations for the
pieces. Happy to forward but not inclined to think it will be useful.
Best,Eileen
Original Message
From: NY
[mailto:
Sent: Friday, Marc 1 01, 2013 5:55 PM
To: Eileen Alexanderson
Subject: Scan from a Xerox Color
Please open the attached document. It was scanned and sent to you using a Xerox Color.
Number of Images: 160
Attachment File Type: PDF
Device Name: NY_730_1 I_XRX_COPYROOM
Device Location:
For more information on Xerox products and solutions, please visit http://www.xerox.com/
This email and any files transmitted with it are confidential
and intended solely for the person or entity to whom they are
addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or
other use of, or taking of any action in reliance upon this
EFTA_R1_00331819
EFTA01901966
information by persons or entities other than the intended recipient is prohibited. If you have received this email in
error please contact the sender and delete the material from
any computer.
Apollo Global Management, LLC
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any pan thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00331820
EFTA01901967
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.